25 XP   0   0   10

Zhejiang Hisun Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Hisun Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Hisun Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Hisun Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Hisun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Hisun Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.33
Expected worth in 1 year
¥8.04
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
¥1.01
Return On Investment
12.3%

For what price can you sell your share?

Current Price per Share
¥8.16
Expected price per share
¥6.43 - ¥9.04
How sure are you?
50%

1. Valuation of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.16

Intrinsic Value Per Share

¥0.07 - ¥24.12

Total Value Per Share

¥7.40 - ¥31.45

2. Growth of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Hisun Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1b$148.9m12.4%

How much money is Zhejiang Hisun Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$21.2m$10.9m$10.2m48.2%
Net Profit Margin5.0%2.8%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Hisun Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Hisun Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Hisun Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Hisun Pharmaceutical Co Ltd is ¥8.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Hisun Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Hisun Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.33. Based on the TTM, the Book Value Change Per Share is ¥0.18 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Hisun Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.1%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.000.0%0.020.3%0.010.2%0.010.1%0.010.1%
Usd Dividend Per Share0.000.1%0.010.1%0.010.1%0.010.2%0.030.3%
Usd Total Gains Per Share0.000.0%0.030.4%0.030.3%0.020.2%0.040.4%
Usd Price Per Share1.51-1.52-1.79-1.71-1.87-
Price to Earnings Ratio87.82-35.29--4.40-26.00-168.88-
Price-to-Total Gains Ratio1,199.99-326.45--32.66-5.08-6.44-
Price to Book Ratio1.50-1.54-2.08-1.92-2.11-
Price-to-Total Gains Ratio1,199.99-326.45--32.66-5.08-6.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.126896
Number of shares887
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.030.02
Gains per Quarter (887 shares)30.8517.16
Gains per Year (887 shares)123.3968.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13687113492059
2731742369840128
310926135914759197
414534848219679266
518243560524499335
6218523728293119404
7254610851342138473
8290697974391158542
93277841097440178611
103638711220489198680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%32.05.03.080.0%79.05.03.090.8%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%28.012.00.070.0%71.016.00.081.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%81.00.06.093.1%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%34.06.00.085.0%81.06.00.093.1%

Fundamentals of Zhejiang Hisun Pharmaceutical Co Ltd

About Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-17 06:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Zhejiang Hisun Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Hisun Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.4% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.4%. The company is making a profit. +1
  • The TTM is 5.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM5.0%-3.6%
TTM5.0%YOY2.8%+2.2%
TTM5.0%5Y2.3%+2.7%
5Y2.3%10Y1.7%+0.6%
1.1.2. Return on Assets

Shows how efficient Zhejiang Hisun Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Assets means that Zhejiang Hisun Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.8%-0.6%
TTM0.8%YOY0.4%+0.4%
TTM0.8%5Y0.3%+0.5%
5Y0.3%10Y0.2%+0.1%
1.1.3. Return on Equity

Shows how efficient Zhejiang Hisun Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Equity means Zhejiang Hisun Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM1.8%-1.4%
TTM1.8%YOY1.1%+0.8%
TTM1.8%5Y0.8%+1.1%
5Y0.8%10Y0.6%+0.2%

1.2. Operating Efficiency of Zhejiang Hisun Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Hisun Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Hisun Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.4%-5.4%
TTM5.4%YOY7.5%-2.1%
TTM5.4%5Y7.0%-1.6%
5Y7.0%10Y3.7%+3.3%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Hisun Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.53 means that the operating costs are ¥1.53 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.535. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.488. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.535TTM1.488+0.046
TTM1.488YOY1.493-0.004
TTM1.4885Y1.508-0.019
5Y1.50810Y1.122+0.385

1.3. Liquidity of Zhejiang Hisun Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.00 means the company has ¥1.00 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.004. The company is just able to pay all its short-term debts.
  • The TTM is 0.955. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.004TTM0.955+0.049
TTM0.955YOY0.774+0.181
TTM0.9555Y0.773+0.183
5Y0.77310Y0.425+0.347
1.3.2. Quick Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.38 means the company can pay off ¥0.38 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.382. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.399. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.382TTM0.399-0.016
TTM0.399YOY0.344+0.055
TTM0.3995Y0.299+0.100
5Y0.29910Y0.278+0.021

1.4. Solvency of Zhejiang Hisun Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Hisun Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Zhejiang Hisun Pharmaceutical Co Ltd assets are financed with 51.2% credit (debt) and the remaining percentage (100% - 51.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.512. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.532. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.532-0.020
TTM0.532YOY0.601-0.069
TTM0.5325Y0.610-0.078
5Y0.61010Y0.601+0.009
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 108.2% means that company has ¥1.08 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.082. The company is able to pay all its debts with equity. +1
  • The TTM is 1.176. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.082TTM1.176-0.093
TTM1.176YOY1.533-0.357
TTM1.1765Y1.783-0.607
5Y1.78310Y1.770+0.013

2. Market Valuation of Zhejiang Hisun Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Hisun Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 87.82 means the investor is paying ¥87.82 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 65.384. Based on the earnings, the company is expensive. -2
  • The MRQ is 87.820. Based on the earnings, the company is expensive. -2
  • The TTM is 35.287. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD65.384MRQ87.820-22.436
MRQ87.820TTM35.287+52.534
TTM35.287YOY-4.404+39.690
TTM35.2875Y26.002+9.285
5Y26.00210Y168.878-142.876
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 4.679. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.284. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.793. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.679MRQ6.284-1.605
MRQ6.284TTM10.793-4.509
TTM10.793YOY19.829-9.036
TTM10.7935Y-407.558+418.351
5Y-407.55810Y-233.912-173.646
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Hisun Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 1.113. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.495. Based on the equity, the company is underpriced. +1
  • The TTM is 1.536. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.113MRQ1.495-0.382
MRQ1.495TTM1.536-0.041
TTM1.536YOY2.078-0.542
TTM1.5365Y1.916-0.380
5Y1.91610Y2.108-0.192
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Hisun Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0220.178-113%0.107-121%0.040-155%0.072-131%
Book Value Per Share--7.3307.170+2%6.280+17%6.528+12%6.490+13%
Current Ratio--1.0040.955+5%0.774+30%0.773+30%0.425+136%
Debt To Asset Ratio--0.5120.532-4%0.601-15%0.610-16%0.601-15%
Debt To Equity Ratio--1.0821.176-8%1.533-29%1.783-39%1.770-39%
Dividend Per Share--0.0310.074-58%0.084-63%0.100-69%0.184-83%
Eps--0.0310.127-75%0.066-53%0.060-48%0.040-22%
Free Cash Flow Per Share--0.4360.318+37%0.312+40%0.169+158%-0.184+142%
Free Cash Flow To Equity Per Share--0.4360.220+98%-0.147+134%-0.094+122%-0.020+105%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Intrinsic Value_10Y_max--24.120--------
Intrinsic Value_10Y_min--0.067--------
Intrinsic Value_1Y_max--1.280--------
Intrinsic Value_1Y_min---0.613--------
Intrinsic Value_3Y_max--4.713--------
Intrinsic Value_3Y_min---1.315--------
Intrinsic Value_5Y_max--9.191--------
Intrinsic Value_5Y_min---1.437--------
Market Cap9856218808.320-34%13238295499.92013300313393.7650%15693250351.360-16%14985167668.961-12%16365596501.873-19%
Net Profit Margin--0.0140.050-72%0.028-49%0.023-38%0.017-14%
Operating Margin---0.054-100%0.075-100%0.070-100%0.037-100%
Operating Ratio--1.5351.488+3%1.493+3%1.508+2%1.122+37%
Pb Ratio1.113-34%1.4951.536-3%2.078-28%1.916-22%2.108-29%
Pe Ratio65.384-34%87.82035.287+149%-4.404+105%26.002+238%168.878-48%
Price Per Share8.160-34%10.96011.0080%12.993-16%12.406-12%13.549-19%
Price To Free Cash Flow Ratio4.679-34%6.28410.793-42%19.829-68%-407.558+6585%-233.912+3822%
Price To Total Gains Ratio893.420-34%1199.986326.454+268%-32.663+103%5.082+23512%6.441+18531%
Quick Ratio--0.3820.399-4%0.344+11%0.299+28%0.278+37%
Return On Assets--0.0020.008-75%0.004-50%0.003-40%0.002-17%
Return On Equity--0.0040.018-76%0.011-59%0.008-42%0.006-27%
Total Gains Per Share--0.0090.252-96%0.191-95%0.140-93%0.256-96%
Usd Book Value--1222625587.0051196406811.904+2%1047469702.954+17%1088956647.235+12%1082560999.267+13%
Usd Book Value Change Per Share---0.0030.025-113%0.015-121%0.006-155%0.010-131%
Usd Book Value Per Share--1.0120.990+2%0.867+17%0.901+12%0.896+13%
Usd Dividend Per Share--0.0040.010-58%0.012-63%0.014-69%0.025-83%
Usd Eps--0.0040.018-75%0.009-53%0.008-48%0.006-22%
Usd Free Cash Flow--72729625.01353135098.542+37%52043759.313+40%28170260.414+158%-30641255.542+142%
Usd Free Cash Flow Per Share--0.0600.044+37%0.043+40%0.023+158%-0.025+142%
Usd Free Cash Flow To Equity Per Share--0.0600.030+98%-0.020+134%-0.013+122%-0.003+105%
Usd Market Cap1361143817.429-34%1828208608.5391836773279.6790%2167237873.523-16%2069451655.084-12%2260088876.909-19%
Usd Price Per Share1.127-34%1.5141.5200%1.794-16%1.713-12%1.871-19%
Usd Profit--5204400.91521235080.258-75%10996421.040-53%9968818.838-48%6713701.058-22%
Usd Revenue--364693423.353414081705.747-12%406460462.376-10%398300979.693-8%369060589.953-1%
Usd Total Gains Per Share--0.0010.035-96%0.026-95%0.019-93%0.035-96%
 EOD+4 -4MRQTTM+15 -20YOY+16 -195Y+15 -2010Y+17 -19

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1565.384
Price to Book Ratio (EOD)Between0-11.113
Net Profit Margin (MRQ)Greater than00.014
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.382
Current Ratio (MRQ)Greater than11.004
Debt to Asset Ratio (MRQ)Less than10.512
Debt to Equity Ratio (MRQ)Less than11.082
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.002
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.845
Ma 20Greater thanMa 507.640
Ma 50Greater thanMa 1007.785
Ma 100Greater thanMa 2008.429
OpenGreater thanClose7.890
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Net Working Capital  -1,078,983355,033-723,950433,368-290,58218,261-272,321301,38029,059



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets18,147,092
Total Liabilities9,293,902
Total Stockholder Equity8,585,911
 As reported
Total Liabilities 9,293,902
Total Stockholder Equity+ 8,585,911
Total Assets = 18,147,092

Assets

Total Assets18,147,092
Total Current Assets6,613,067
Long-term Assets11,534,025
Total Current Assets
Cash And Cash Equivalents 1,565,482
Net Receivables 2,517,480
Inventory 1,876,002
Other Current Assets 35,211
Total Current Assets  (as reported)6,613,067
Total Current Assets  (calculated)5,994,175
+/- 618,892
Long-term Assets
Property Plant Equipment 8,500,532
Intangible Assets 1,401,691
Long-term Assets Other 55,088
Long-term Assets  (as reported)11,534,025
Long-term Assets  (calculated)9,957,311
+/- 1,576,713

Liabilities & Shareholders' Equity

Total Current Liabilities6,584,008
Long-term Liabilities2,709,894
Total Stockholder Equity8,585,911
Total Current Liabilities
Short Long Term Debt 2,607,533
Accounts payable 1,203,284
Other Current Liabilities 4,905
Total Current Liabilities  (as reported)6,584,008
Total Current Liabilities  (calculated)3,815,722
+/- 2,768,286
Long-term Liabilities
Long term Debt 2,461,516
Capital Lease Obligations Min Short Term Debt34,129
Long-term Liabilities  (as reported)2,709,894
Long-term Liabilities  (calculated)2,495,645
+/- 214,248
Total Stockholder Equity
Retained Earnings 2,570,408
Total Stockholder Equity (as reported)8,585,911
Total Stockholder Equity (calculated)2,570,408
+/- 6,015,503
Other
Capital Stock1,207,874
Common Stock Shares Outstanding 1,207,874
Net Debt 3,503,567
Net Invested Capital 13,654,960
Net Working Capital 29,059
Property Plant and Equipment Gross 8,500,532



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
777,198
1,206,908
1,231,372
1,298,922
1,374,008
1,434,423
1,486,064
1,575,522
1,644,320
1,708,083
1,825,368
1,873,739
2,020,444
2,080,158
2,153,777
2,179,803
2,345,734
2,526,206
2,501,048
2,605,873
2,741,543
2,749,415
2,817,929
2,812,740
2,943,264
2,948,134
3,047,332
2,985,559
3,229,486
3,536,061
3,861,713
4,121,317
4,595,110
4,669,740
4,885,436
5,198,691
5,487,179
5,685,048
5,806,183
5,921,673
7,660,324
7,662,898
8,000,510
8,230,982
8,804,592
9,092,532
9,682,803
10,569,092
11,638,866
12,206,017
12,801,218
13,972,087
14,591,619
15,404,513
17,368,920
17,298,304
17,444,486
18,081,624
18,388,592
19,174,426
20,478,984
20,560,581
20,031,835
20,758,273
21,133,755
21,376,669
21,909,876
21,636,419
21,747,044
22,179,419
22,162,374
21,853,646
21,865,687
22,286,678
24,592,136
21,465,563
21,718,947
21,534,681
21,281,423
20,859,772
19,917,601
19,886,752
19,960,204
19,374,263
19,466,614
18,813,220
18,538,504
18,777,887
18,837,252
18,333,813
18,147,092
18,147,09218,333,81318,837,25218,777,88718,538,50418,813,22019,466,61419,374,26319,960,20419,886,75219,917,60120,859,77221,281,42321,534,68121,718,94721,465,56324,592,13622,286,67821,865,68721,853,64622,162,37422,179,41921,747,04421,636,41921,909,87621,376,66921,133,75520,758,27320,031,83520,560,58120,478,98419,174,42618,388,59218,081,62417,444,48617,298,30417,368,92015,404,51314,591,61913,972,08712,801,21812,206,01711,638,86610,569,0929,682,8039,092,5328,804,5928,230,9828,000,5107,662,8987,660,3245,921,6735,806,1835,685,0485,487,1795,198,6914,885,4364,669,7404,595,1104,121,3173,861,7133,536,0613,229,4862,985,5593,047,3322,948,1342,943,2642,812,7402,817,9292,749,4152,741,5432,605,8732,501,0482,526,2062,345,7342,179,8032,153,7772,080,1582,020,4441,873,7391,825,3681,708,0831,644,3201,575,5221,486,0641,434,4231,374,0081,298,9221,231,3721,206,908777,198
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,075,265
6,674,348
6,087,791
6,007,709
6,371,422
9,251,226
7,684,307
8,101,549
7,755,777
7,585,946
7,347,865
6,331,215
6,470,901
6,758,314
6,363,985
6,535,883
6,028,374
6,129,953
6,409,130
6,742,231
6,464,347
6,613,067
6,613,0676,464,3476,742,2316,409,1306,129,9536,028,3746,535,8836,363,9856,758,3146,470,9016,331,2157,347,8657,585,9467,755,7778,101,5497,684,3079,251,2266,371,4226,007,7096,087,7916,674,3487,075,265000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,109,927
2,264,646
1,894,516
1,548,737
1,310,228
1,990,517
1,764,160
2,332,702
1,504,574
2,121,077
2,059,091
1,042,942
1,109,765
1,542,255
1,295,750
1,557,076
1,309,236
1,264,694
1,398,783
1,580,441
1,341,697
1,565,482
1,565,4821,341,6971,580,4411,398,7831,264,6941,309,2361,557,0761,295,7501,542,2551,109,7651,042,9422,059,0912,121,0771,504,5742,332,7021,764,1601,990,5171,310,2281,548,7371,894,5162,264,6462,109,927000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125,000
0
0
20,174
0
0
0
0
3
3
358
1,663
993
1,692
3,053
4,359
1,747
684
0
0
0
0
00006841,7474,3593,0531,6929931,66335833000020,17400125,000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
93,746
126,558
135,539
111,633
137,782
154,913
153,255
139,141
169,063
169,406
200,150
229,639
297,395
298,750
340,492
221,398
326,466
319,731
316,008
262,588
395,401
410,824
425,806
389,529
471,358
473,234
465,498
404,983
469,255
524,283
553,586
532,966
616,684
678,687
823,073
723,105
791,340
733,036
758,546
755,259
847,309
923,057
927,254
882,810
1,149,216
1,083,744
1,193,755
998,095
1,622,686
1,500,896
1,874,578
1,439,296
1,599,451
1,601,709
1,895,523
1,732,117
1,881,355
1,721,234
1,476,003
1,358,075
1,623,307
1,737,812
1,704,670
1,482,639
1,826,477
1,964,411
1,862,841
1,578,188
1,840,670
2,108,645
1,753,734
1,685,906
1,796,953
2,020,033
2,171,242
3,460,155
3,264,742
3,361,841
2,469,437
2,253,233
2,274,212
2,626,481
2,672,708
2,653,014
2,751,545
2,713,659
2,954,442
2,802,094
2,980,257
2,664,851
2,517,480
2,517,4802,664,8512,980,2572,802,0942,954,4422,713,6592,751,5452,653,0142,672,7082,626,4812,274,2122,253,2332,469,4373,361,8413,264,7423,460,1552,171,2422,020,0331,796,9531,685,9061,753,7342,108,6451,840,6701,578,1881,862,8411,964,4111,826,4771,482,6391,704,6701,737,8121,623,3071,358,0751,476,0031,721,2341,881,3551,732,1171,895,5231,601,7091,599,4511,439,2961,874,5781,500,8961,622,686998,0951,193,7551,083,7441,149,216882,810927,254923,057847,309755,259758,546733,036791,340723,105823,073678,687616,684532,966553,586524,283469,255404,983465,498473,234471,358389,529425,806410,824395,401262,588316,008319,731326,466221,398340,492298,750297,395229,639200,150169,406169,063139,141153,255154,913137,782111,633135,539126,55893,746
       Other Current Assets 
4,877
40,541
7,711
5,207
13,724
13,711
12,971
9,548
3,785
10,485
7,578
25,845
23,630
27,327
24,398
21,310
17,342
12,278
22,888
23,422
44,916
33,399
46,016
41,257
60,426
68,427
47,201
68,244
115,266
93,770
117,070
128,008
104,754
95,490
119,859
107,044
92,687
95,939
107,821
94,625
131,302
111,344
110,995
93,028
122,464
139,390
106,709
548,466
566,188
487,021
529,204
452,582
391,309
468,018
515,182
557,052
946,022
601,626
1,212,038
589,695
1,102,872
665,489
1,197,679
684,423
916,391
764,331
1,154,129
756,447
1,107,535
726,697
594,354
492,366
352,154
447,298
258,055
477,197
506,947
576,574
581,779
470,344
570,047
357,867
396,612
389,286
414,954
312,303
274,149
39,213
282,014
36,507
35,211
35,21136,507282,01439,213274,149312,303414,954389,286396,612357,867570,047470,344581,779576,574506,947477,197258,055447,298352,154492,366594,354726,6971,107,535756,4471,154,129764,331916,391684,4231,197,679665,4891,102,872589,6951,212,038601,626946,022557,052515,182468,018391,309452,582529,204487,021566,188548,466106,709139,390122,46493,028110,995111,344131,30294,625107,82195,93992,687107,044119,85995,490104,754128,008117,07093,770115,26668,24447,20168,42760,42641,25746,01633,39944,91623,42222,88812,27817,34221,31024,39827,32723,63025,8457,57810,4853,7859,54812,97113,71113,7245,2077,71140,5414,877
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,857,978
15,915,256
15,340,909
13,781,257
13,617,398
13,778,904
13,695,477
13,511,907
13,586,386
13,415,851
13,201,890
13,010,278
12,930,731
12,784,846
12,408,551
12,368,757
12,095,021
11,869,466
11,534,025
11,534,02511,869,46612,095,02112,368,75712,408,55112,784,84612,930,73113,010,27813,201,89013,415,85113,586,38613,511,90713,695,47713,778,90413,617,39813,781,25715,340,90915,915,25615,857,978000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
491,653
557,992
683,862
784,729
856,887
907,138
941,283
996,156
1,038,670
1,089,996
1,143,443
1,192,492
1,249,205
1,284,083
1,320,423
1,394,993
1,448,001
1,532,439
1,518,174
1,583,510
1,558,678
1,641,543
1,649,483
1,726,785
1,596,665
1,795,647
1,685,378
1,887,525
1,769,847
2,079,630
2,087,642
2,434,697
2,313,724
2,746,446
2,601,800
3,048,819
2,910,894
3,272,234
3,140,965
3,667,157
3,564,816
4,152,210
4,093,022
4,652,048
4,581,949
5,256,258
5,328,132
5,929,638
5,987,418
6,682,981
6,700,257
7,579,114
7,629,457
8,082,670
8,714,944
9,150,311
9,556,852
9,823,039
10,111,733
10,525,460
10,728,272
10,963,384
11,135,718
11,515,478
11,712,784
11,856,361
11,927,365
12,125,578
12,124,656
12,298,125
12,495,205
12,636,854
12,698,978
12,671,104
11,759,447
10,781,078
10,668,791
10,592,790
10,533,591
10,369,413
10,236,311
10,097,186
9,956,511
9,753,838
9,628,363
9,450,103
9,179,389
9,100,515
8,875,390
8,697,435
8,500,532
8,500,5328,697,4358,875,3909,100,5159,179,3899,450,1039,628,3639,753,8389,956,51110,097,18610,236,31110,369,41310,533,59110,592,79010,668,79110,781,07811,759,44712,671,10412,698,97812,636,85412,495,20512,298,12512,124,65612,125,57811,927,36511,856,36111,712,78411,515,47811,135,71810,963,38410,728,27210,525,46010,111,7339,823,0399,556,8529,150,3118,714,9448,082,6707,629,4577,579,1146,700,2576,682,9815,987,4185,929,6385,328,1325,256,2584,581,9494,652,0484,093,0224,152,2103,564,8163,667,1573,140,9653,272,2342,910,8943,048,8192,601,8002,746,4462,313,7242,434,6972,087,6422,079,6301,769,8471,887,5251,685,3781,795,6471,596,6651,726,7851,649,4831,641,5431,558,6781,583,5101,518,1741,532,4391,448,0011,394,9931,320,4231,284,0831,249,2051,192,4921,143,4431,089,9961,038,670996,156941,283907,138856,887784,729683,862557,992491,653
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,790
11,790
11,790
11,790
11,790
11,790
102,351
92,603
92,603
92,603
92,603
68,123
68,123
68,123
68,123
40,895
40,895
40,895
40,895
26,471
26,471
26,471
26,471
1,421
1,421
1,421
1,421
1,421
1,421
1,421
1,421
1,421
1,421
0
0
0
0
0
0
0000001,4211,4211,4211,4211,4211,4211,4211,4211,4211,42126,47126,47126,47126,47140,89540,89540,89540,89568,12368,12368,12368,12392,60392,60392,60392,603102,35111,79011,79011,79011,79011,79011,7900000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
338,098
342,580
352,113
309,328
335,916
1,321,939
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,321,939335,916309,328352,113342,580338,098000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
45,102
48,971
51,972
57,313
59,181
65,953
67,321
73,051
82,358
75,163
72,312
62,545
61,220
60,751
59,362
55,302
54,014
11,274
51,438
9,222
48,857
7,811
53,932
4,821
169,029
2,853
172,505
1,846
177,286
12,997
251,651
19,293
328,767
22,747
346,946
51,666
377,371
63,958
355,835
59,793
379,631
61,212
389,464
149,880
529,921
205,000
533,503
205,357
632,044
228,967
624,027
250,795
685,966
695,577
714,365
738,851
735,542
769,524
891,279
906,771
916,508
930,194
917,429
916,115
939,249
905,046
900,640
837,396
850,060
844,832
874,664
1,047,317
2,476,030
2,026,431
1,854,351
1,351,760
1,377,326
1,335,714
1,319,653
1,341,658
1,338,163
1,357,535
1,380,101
1,593,238
1,630,082
1,596,926
1,547,270
1,520,647
1,486,296
1,435,661
1,401,691
1,401,6911,435,6611,486,2961,520,6471,547,2701,596,9261,630,0821,593,2381,380,1011,357,5351,338,1631,341,6581,319,6531,335,7141,377,3261,351,7601,854,3512,026,4312,476,0301,047,317874,664844,832850,060837,396900,640905,046939,249916,115917,429930,194916,508906,771891,279769,524735,542738,851714,365695,577685,966250,795624,027228,967632,044205,357533,503205,000529,921149,880389,46461,212379,63159,793355,83563,958377,37151,666346,94622,747328,76719,293251,65112,997177,2861,846172,5052,853169,0294,82153,9327,81148,8579,22251,43811,27454,01455,30259,36260,75161,22062,54572,31275,16382,35873,05167,32165,95359,18157,31351,97248,97145,102
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178,128
197,101
177,089
50,156
48,694
123,788
160,995
10,553,668
212,601
201,821
187,178
61,830
63,662
63,925
51,261
52,006
51,353
54,630
55,088
55,08854,63051,35352,00651,26163,92563,66261,830187,178201,821212,60110,553,668160,995123,78848,69450,156177,089197,101178,128000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
504,675
449,008
446,468
514,745
581,495
632,401
674,097
750,693
800,086
822,467
890,151
871,955
962,594
988,157
1,011,338
977,761
1,109,275
1,322,744
1,271,943
1,377,880
1,485,292
1,526,783
1,579,415
1,542,184
1,623,935
1,651,107
1,711,665
1,608,539
1,806,713
2,101,876
2,372,278
2,572,096
3,039,717
3,055,211
3,183,610
2,768,079
2,982,867
3,161,508
3,185,413
3,177,438
3,478,673
3,430,553
3,644,174
3,637,422
4,137,064
4,418,854
4,934,846
5,371,378
6,316,339
6,828,772
7,409,194
8,013,892
8,493,830
9,311,788
9,189,425
9,033,647
9,138,289
9,941,074
10,237,092
11,009,168
12,270,960
12,491,033
11,890,551
12,719,040
13,014,576
13,246,574
13,737,771
13,761,135
13,738,750
14,323,878
14,284,270
14,475,028
14,331,048
14,682,188
15,778,845
13,783,024
14,142,207
13,490,444
13,121,372
12,603,176
12,892,404
12,728,225
12,482,407
12,028,750
11,971,822
11,308,451
10,544,122
10,447,695
10,259,397
9,441,704
9,293,902
9,293,9029,441,70410,259,39710,447,69510,544,12211,308,45111,971,82212,028,75012,482,40712,728,22512,892,40412,603,17613,121,37213,490,44414,142,20713,783,02415,778,84514,682,18814,331,04814,475,02814,284,27014,323,87813,738,75013,761,13513,737,77113,246,57413,014,57612,719,04011,890,55112,491,03312,270,96011,009,16810,237,0929,941,0749,138,2899,033,6479,189,4259,311,7888,493,8308,013,8927,409,1946,828,7726,316,3395,371,3784,934,8464,418,8544,137,0643,637,4223,644,1743,430,5533,478,6733,177,4383,185,4133,161,5082,982,8672,768,0793,183,6103,055,2113,039,7172,572,0962,372,2782,101,8761,806,7131,608,5391,711,6651,651,1071,623,9351,542,1841,579,4151,526,7831,485,2921,377,8801,271,9431,322,7441,109,275977,7611,011,338988,157962,594871,955890,151822,467800,086750,693674,097632,401581,495514,745446,468449,008504,675
   > Total Current Liabilities 
287,350
231,775
221,118
311,745
378,495
451,402
493,097
655,273
734,666
782,047
784,731
709,748
756,603
801,800
825,489
810,350
941,863
1,135,259
1,168,827
1,262,056
1,392,941
1,399,433
1,392,065
1,367,534
1,359,385
1,396,357
1,436,815
1,324,539
1,582,713
1,725,741
1,896,144
1,975,522
2,043,142
1,878,637
1,963,865
1,485,094
1,673,965
1,725,431
1,690,763
1,579,277
1,861,082
1,727,028
1,558,598
1,580,466
1,921,695
2,188,124
2,513,138
2,930,404
3,646,973
3,841,971
4,326,993
5,085,912
5,321,940
6,140,791
6,227,721
5,439,994
5,311,859
5,973,958
5,299,915
6,582,700
6,407,943
7,115,895
6,367,449
7,346,169
7,560,084
8,214,327
8,127,474
8,080,989
8,030,437
8,673,997
8,989,697
9,556,936
9,628,164
10,113,412
11,213,444
9,929,312
11,545,247
11,052,943
10,607,583
10,530,286
9,037,293
8,687,731
8,615,909
8,784,874
8,598,632
7,919,946
7,208,936
7,133,080
7,032,813
6,736,668
6,584,008
6,584,0086,736,6687,032,8137,133,0807,208,9367,919,9468,598,6328,784,8748,615,9098,687,7319,037,29310,530,28610,607,58311,052,94311,545,2479,929,31211,213,44410,113,4129,628,1649,556,9368,989,6978,673,9978,030,4378,080,9898,127,4748,214,3277,560,0847,346,1696,367,4497,115,8956,407,9436,582,7005,299,9155,973,9585,311,8595,439,9946,227,7216,140,7915,321,9405,085,9124,326,9933,841,9713,646,9732,930,4042,513,1382,188,1241,921,6951,580,4661,558,5981,727,0281,861,0821,579,2771,690,7631,725,4311,673,9651,485,0941,963,8651,878,6372,043,1421,975,5221,896,1441,725,7411,582,7131,324,5391,436,8151,396,3571,359,3851,367,5341,392,0651,399,4331,392,9411,262,0561,168,8271,135,259941,863810,350825,489801,800756,603709,748784,731782,047734,666655,273493,097451,402378,495311,745221,118231,775287,350
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
441,513
457,838
896,585
5,813,809
5,755,757
5,905,637
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,905,6375,755,7575,813,809896,585457,838441,513000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
441,513
457,838
896,585
5,813,809
5,755,757
5,905,637
4,456,149
5,134,893
5,178,047
5,083,611
5,111,621
5,139,149
4,549,334
4,128,580
3,988,481
4,235,666
3,737,110
2,730,929
2,399,408
2,693,503
2,732,309
2,607,533
2,607,5332,732,3092,693,5032,399,4082,730,9293,737,1104,235,6663,988,4814,128,5804,549,3345,139,1495,111,6215,083,6115,178,0475,134,8934,456,1495,905,6375,755,7575,813,809896,585457,838441,513000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
57,084
69,235
75,837
82,931
98,794
102,533
116,309
149,462
188,716
203,293
194,793
200,602
204,239
219,916
238,307
235,968
261,813
311,286
325,268
318,892
347,880
265,586
291,172
288,319
303,904
285,669
351,943
293,643
331,216
400,684
375,162
387,867
387,886
396,224
503,445
481,219
491,032
578,837
553,257
529,641
553,574
583,492
586,798
557,167
680,918
771,254
969,187
773,240
1,130,892
1,226,383
1,309,056
1,072,369
990,757
967,040
1,237,865
890,440
1,093,130
1,057,029
1,328,452
1,028,252
1,185,471
930,747
1,068,237
842,294
1,121,544
863,682
1,076,430
793,246
1,093,979
908,514
1,440,119
1,008,130
1,203,536
1,465,027
1,521,966
1,123,845
1,330,887
1,402,331
1,554,102
1,355,172
1,528,830
1,418,644
1,411,931
1,037,340
1,316,495
1,236,921
1,248,440
1,302,666
1,284,389
1,173,669
1,203,284
1,203,2841,173,6691,284,3891,302,6661,248,4401,236,9211,316,4951,037,3401,411,9311,418,6441,528,8301,355,1721,554,1021,402,3311,330,8871,123,8451,521,9661,465,0271,203,5361,008,1301,440,119908,5141,093,979793,2461,076,430863,6821,121,544842,2941,068,237930,7471,185,4711,028,2521,328,4521,057,0291,093,130890,4401,237,865967,040990,7571,072,3691,309,0561,226,3831,130,892773,240969,187771,254680,918557,167586,798583,492553,574529,641553,257578,837491,032481,219503,445396,224387,886387,867375,162400,684331,216293,643351,943285,669303,904288,319291,172265,586347,880318,892325,268311,286261,813235,968238,307219,916204,239200,602194,793203,293188,716149,462116,309102,53398,79482,93175,83769,23557,084
       Other Current Liabilities 
101,566
113,540
95,281
119,614
128,501
103,669
102,788
136,811
141,950
170,754
239,938
255,070
302,314
186,853
227,151
184,313
214,998
241,927
198,489
203,012
185,819
189,624
199,000
169,681
190,021
192,688
276,872
255,896
274,497
289,557
372,482
345,155
378,156
352,813
336,820
299,875
291,933
313,594
335,066
323,977
343,211
276,778
325,416
292,943
274,674
323,424
249,217
483,041
561,615
664,140
754,906
736,682
613,432
984,504
771,599
1,104,825
783,470
1,105,236
744,156
1,024,971
810,873
1,059,254
727,415
1,310,054
1,066,735
1,548,857
1,277,882
1,577,840
1,400,437
1,264,577
1,110,134
933,310
1,110,136
1,106,468
686,844
911,455
1,607,737
589,679
1,473,685
833,160
1,440,369
587,183
1,743,706
1,071,185
2,299,631
731,168
2,265,605
915,696
1,961,947
412,330
4,905
4,905412,3301,961,947915,6962,265,605731,1682,299,6311,071,1851,743,706587,1831,440,369833,1601,473,685589,6791,607,737911,455686,8441,106,4681,110,136933,3101,110,1341,264,5771,400,4371,577,8401,277,8821,548,8571,066,7351,310,054727,4151,059,254810,8731,024,971744,1561,105,236783,4701,104,825771,599984,504613,432736,682754,906664,140561,615483,041249,217323,424274,674292,943325,416276,778343,211323,977335,066313,594291,933299,875336,820352,813378,156345,155372,482289,557274,497255,896276,872192,688190,021169,681199,000189,624185,819203,012198,489241,927214,998184,313227,151186,853302,314255,070239,938170,754141,950136,811102,788103,669128,501119,61495,281113,540101,566
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,702,884
4,568,775
4,565,402
3,853,713
2,596,960
2,437,501
2,513,789
2,072,890
3,855,111
4,040,494
3,866,498
3,243,876
3,373,190
3,388,505
3,335,186
3,314,615
3,226,584
2,705,036
2,709,894
2,709,8942,705,0363,226,5843,314,6153,335,1863,388,5053,373,1903,243,8763,866,4984,040,4943,855,1112,072,8902,513,7892,437,5012,596,9603,853,7134,565,4024,568,7754,702,884000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-441,513
-457,838
-896,585
-5,813,809
-5,755,757
-5,905,637
0
0
0
0
0
13,007
11,601
9,220
37,557
39,197
38,899
37,243
32,380
36,925
35,641
34,129
34,12935,64136,92532,38037,24338,89939,19737,5579,22011,60113,00700000-5,905,637-5,755,757-5,813,809-896,585-457,838-441,513000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,068,316
3,841,423
152,200
602,200
657,355
661,118
661,118
661,118
661,118
661,118
486,118
211,118
211,118
211,118
211,118
0
0
0
0
0000211,118211,118211,118211,118486,118661,118661,118661,118661,118661,118657,355602,200152,2003,841,4234,068,316000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,186,991
1,317,951
1,353,467
1,477,627
1,504,308
943,941
606,198
635,863
623,570
588,497
621,841
613,060
316,528
181,981
187,170
186,942
187,649
192,373
194,454
196,788
0
0
00196,788194,454192,373187,649186,942187,170181,981316,528613,060621,841588,497623,570635,863606,198943,9411,504,3081,477,6271,353,4671,317,9511,186,991000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
258,217
743,927
770,638
764,801
772,333
781,213
790,594
802,531
821,733
864,469
913,535
975,686
1,031,486
1,065,617
1,115,401
1,174,318
1,208,340
1,174,579
1,199,784
1,209,877
1,235,148
1,199,157
1,216,897
1,248,918
1,296,500
1,274,645
1,316,449
1,363,002
1,407,574
1,400,842
1,454,240
1,513,395
1,517,886
1,574,968
1,662,300
2,390,717
2,456,905
2,481,694
2,575,282
2,698,132
4,133,748
4,180,781
4,302,821
4,500,434
4,570,700
4,558,928
4,632,386
4,685,961
4,762,645
4,760,994
4,782,338
4,886,816
4,961,049
4,966,493
6,973,329
7,023,938
7,028,859
6,954,496
6,916,288
6,919,578
6,925,766
6,870,386
6,880,824
6,755,160
6,761,616
6,721,285
6,714,106
6,722,515
6,735,804
6,688,234
6,678,228
6,183,497
6,216,103
6,235,064
7,438,353
6,274,220
6,197,840
6,610,924
6,650,159
6,678,665
6,997,649
7,133,585
7,354,714
7,303,285
7,451,679
7,465,537
7,738,879
8,079,089
8,317,395
8,629,051
8,585,911
8,585,9118,629,0518,317,3958,079,0897,738,8797,465,5377,451,6797,303,2857,354,7147,133,5856,997,6496,678,6656,650,1596,610,9246,197,8406,274,2207,438,3536,235,0646,216,1036,183,4976,678,2286,688,2346,735,8046,722,5156,714,1066,721,2856,761,6166,755,1606,880,8246,870,3866,925,7666,919,5786,916,2886,954,4967,028,8597,023,9386,973,3294,966,4934,961,0494,886,8164,782,3384,760,9944,762,6454,685,9614,632,3864,558,9284,570,7004,500,4344,302,8214,180,7814,133,7482,698,1322,575,2822,481,6942,456,9052,390,7171,662,3001,574,9681,517,8861,513,3951,454,2401,400,8421,407,5741,363,0021,316,4491,274,6451,296,5001,248,9181,216,8971,199,1571,235,1481,209,8771,199,7841,174,5791,208,3401,174,3181,115,4011,065,6171,031,486975,686913,535864,469821,733802,531790,594781,213772,333764,801770,638743,927258,217
   Common Stock
116,000
156,000
249,600
249,600
249,600
249,600
249,600
249,600
249,600
249,600
249,600
249,600
249,600
249,600
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
449,280
483,780
483,780
483,780
483,780
483,780
524,818
524,818
524,818
524,818
524,818
839,709
839,709
839,709
839,709
839,709
839,709
839,709
839,709
839,709
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
965,532
1,168,843
1,168,843
1,196,205
1,196,032
1,198,658
1,198,182
1,198,182
0
1,180,390
0
0
001,180,39001,198,1821,198,1821,198,6581,196,0321,196,2051,168,8431,168,843965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532965,532839,709839,709839,709839,709839,709839,709839,709839,709839,709524,818524,818524,818524,818524,818483,780483,780483,780483,780483,780449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280449,280249,600249,600249,600249,600249,600249,600249,600249,600249,600249,600249,600249,600156,000116,000
   Retained Earnings 
72,885
78,526
53,796
38,093
45,625
54,505
63,886
65,700
84,902
127,638
176,705
203,416
259,215
293,346
343,130
337,895
371,916
338,156
363,361
353,358
380,685
345,207
358,647
379,855
426,957
403,749
445,554
479,555
524,127
517,395
570,793
612,379
616,871
673,952
761,285
813,713
879,900
904,727
998,052
1,089,766
1,191,316
1,238,440
1,360,631
1,472,893
1,577,249
1,564,982
1,642,129
1,676,393
1,750,883
1,744,495
1,798,867
1,876,061
2,265,577
2,267,228
2,324,657
2,405,518
2,410,576
2,336,066
2,303,741
2,306,177
2,312,249
2,258,931
2,269,594
2,144,161
2,150,993
2,109,389
2,100,996
2,109,451
2,120,242
2,076,019
2,067,085
1,568,700
1,256,241
1,277,136
2,482,274
1,661,773
1,590,362
1,854,162
1,956,060
2,030,749
2,156,472
2,265,908
2,502,543
2,500,419
2,640,935
2,658,549
2,670,627
2,312,398
3,060,892
2,532,722
2,570,408
2,570,4082,532,7223,060,8922,312,3982,670,6272,658,5492,640,9352,500,4192,502,5432,265,9082,156,4722,030,7491,956,0601,854,1621,590,3621,661,7732,482,2741,277,1361,256,2411,568,7002,067,0852,076,0192,120,2422,109,4512,100,9962,109,3892,150,9932,144,1612,269,5942,258,9312,312,2492,306,1772,303,7412,336,0662,410,5762,405,5182,324,6572,267,2282,265,5771,876,0611,798,8671,744,4951,750,8831,676,3931,642,1291,564,9821,577,2491,472,8931,360,6311,238,4401,191,3161,089,766998,052904,727879,900813,713761,285673,952616,871612,379570,793517,395524,127479,555445,554403,749426,957379,855358,647345,207380,685353,358363,361338,156371,916337,895343,130293,346259,215203,416176,705127,63884,90265,70063,88654,50545,62538,09353,79678,52672,885
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,081
-4,151
-498
377
-1,558
-2,777
-2,168
-7,137
142,173
79,511
49,689
462,989
470,235
446,538
433,981
428,756
434,974
441,285
439,188
437,799
354,930
0
0354,930437,799439,188441,285434,974428,756433,981446,538470,235462,98949,68979,511142,173-7,137-2,168-2,777-1,558377-498-4,151-3,081000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,993,677
Cost of Revenue-6,949,393
Gross Profit5,044,2845,044,284
 
Operating Income (+$)
Gross Profit5,044,284
Operating Expense-10,878,554
Operating Income1,115,123-5,834,270
 
Operating Expense (+$)
Research Development454,232
Selling General Administrative2,706,101
Selling And Marketing Expenses-
Operating Expense10,878,5543,160,333
 
Net Interest Income (+$)
Interest Income28,381
Interest Expense-230,354
Other Finance Cost-13,251
Net Interest Income-215,224
 
Pretax Income (+$)
Operating Income1,115,123
Net Interest Income-215,224
Other Non-Operating Income Expenses-
Income Before Tax (EBT)776,6091,115,123
EBIT - interestExpense = -230,354
614,980
845,334
Interest Expense230,354
Earnings Before Interest and Taxes (EBIT)-1,006,963
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax776,609
Tax Provision-150,525
Net Income From Continuing Ops626,084626,084
Net Income614,980
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-215,224
 

Technical Analysis of Zhejiang Hisun Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Hisun Pharmaceutical Co Ltd. The general trend of Zhejiang Hisun Pharmaceutical Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Hisun Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Hisun Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 8.22 < 8.41 < 9.04.

The bearish price targets are: 7.99 > 7.27 > 6.43.

Tweet this
Zhejiang Hisun Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Hisun Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Hisun Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Hisun Pharmaceutical Co Ltd. The current macd is -0.01722033.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Hisun Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Hisun Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Hisun Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current adx is 23.29.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Hisun Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Hisun Pharmaceutical Co Ltd. The current sar is 7.32784832.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current rsi is 63.85. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Hisun Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Hisun Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current cci is 172.85.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Hisun Pharmaceutical Co Ltd. The current cmo is 46.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Hisun Pharmaceutical Co Ltd. The current willr is -9.18367347.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Hisun Pharmaceutical Co Ltd.

Zhejiang Hisun Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Hisun Pharmaceutical Co Ltd. The current atr is 0.21941123.

Zhejiang Hisun Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Hisun Pharmaceutical Co Ltd. The current obv is -14,607,639.

Zhejiang Hisun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current mfi is 60.17.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Hisun Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Zhejiang Hisun Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.845
Ma 20Greater thanMa 507.640
Ma 50Greater thanMa 1007.785
Ma 100Greater thanMa 2008.429
OpenGreater thanClose7.890
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Hisun Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Hisun Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Hisun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Hisun Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Hisun Pharmaceutical Co Ltd in your mailbox!